Marjorie Leduc

Marjorie Leduc

Auto-generated profile, based on publicly available information

Marjorie Leduc

Proteom’IC facility, Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in Blood
Verified
Journal Article
Closed access
SGSalomé Le Goff
Salomé Le Goff
IBIsmael Boussaid
Ismael Boussaid
CFCelia Floquet
Celia Floquet
ARAnna Raimbault
Anna Raimbault
IHIsabelle Hatin
Isabelle Hatin
MFMichaela Fontenay
Michaela Fontenay
The role of ribosome biogenesis in erythroid development is supported by the recognition of erythroid defects in ribosomopathies in both Diamond-Blackfan anemia and 5q− syndrome. Whether ribosome biogenesis exerts a regulatory function on normal erythroid development is still unknown. In the present study, a detailed characterization of ribosome biogenesis dynamics during human and murine erythropoiesis showed that ribosome biogenesis is abruptly interrupted by the decline in ribosomal DNA transcription and the collapse of ribosomal protein neosynthesis. Its premature arrest by the RNA Pol I inhibitor CX-5461 targeted the proliferation of immature erythroblasts. p53 was activated spontaneously or in response to CX-5461, concomitant to ribosome biogenesis arrest, and drove a transcriptional program in which genes involved in cell cycle–arrested, negative regulation of apoptosis, and DNA damage response were upregulated. RNA Pol I transcriptional stress resulted in nucleolar disruption and activation of the ATR-CHK1-p53 pathway. Our results imply that the timing of ribosome biogenesis extinction and p53 activation is crucial for erythroid development. In ribosomopathies in which ribosome availability is altered by unbalanced production of ribosomal proteins, the threshold downregulation of ribosome biogenesis could be prematurely reached and, together with pathological p53 activation, prevents a normal expansion of erythroid progenitors.

13 April 2020 in Blood Advances
Verified
Journal Article
Open access
PDF file
EGEmilie-Fleur GAUTIER
Emilie-Fleur GAUTIER
MLMarjorie Leduc
Marjorie Leduc
MLMeriem Ladli
Meriem Ladli
VSVincent P. Schulz
Vincent P. Schulz
CLCarine Lefèvre
Carine Lefèvre
PMPatrick Mayeux
Patrick Mayeux
Murine-based cellular models have provided and continue to provide many useful insights into the fundamental mechanisms of erythropoiesis, as well as insights into the pathophysiology of inherited and acquired red cell disorders. Although detailed information on many aspects of these cell models is available, comprehensive proteomic data are lacking. This is a critical knowledge gap, as proteins are effectors of most biologic processes. To address this critical unmet need, proteomes of the murine cell lines Friend erythroleukemia (MEL), GATA1 erythroid (G1ER), and embryonic stem cell–derived erythroid progenitor (MEDEP) and proteomes of cultured murine marrow–derived erythroblasts at different stages of terminal erythroid differentiation were analyzed. The proteomes of MEDEP cells and primary murine erythroid cells were most similar, whereas those of MEL and G1ER cells were more distantly related. We demonstrated that the overall cellular content of histones does not decrease during terminal differentiation, despite strong chromatin condensation. Comparison of murine and human proteomes throughout terminal erythroid differentiation revealed that many noted transcriptomic changes were significantly dampened at the proteome level, especially at the end of the terminal differentiation process. Analysis of the early events associated with induction of terminal differentiation in MEDEP cells revealed divergent alterations in associated transcriptomes and proteomes. These proteomic data are powerful and valuable tools for the study of fundamental mechanisms of normal and disordered erythropoiesis and will be of broad interest to a wide range of investigators for making the appropriate choice of various cell lines to study inherited and acquired diseases of the erythrocyte.

8 April 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
DRDavid Rombaut
David Rombaut
CLCarine Lefèvre
Carine Lefèvre
TRTony Rached
Tony Rached
SBSabrina Bondu
Sabrina Bondu
ALAnne Letessier
Anne Letessier
MFMichaela Fontenay
Michaela Fontenay
Myelodysplastic syndromes (MDS) with mutated SF3B1 gene present features including a favourable outcome distinct from MDS with mutations in other splicing factor genes SRSF2 or U2AF1. Molecular bases of these divergences are poorly understood. Here we find that SF3B1-mutated MDS show reduced R-loop formation predominating in gene bodies associated with intron retention reduction, not found in U2AF1- or SRSF2-mutated MDS. Compared to erythroblasts from SRSF2- or U2AF1-mutated patients, SF3B1-mutated erythroblasts exhibit augmented DNA synthesis, accelerated replication forks, and single-stranded DNA exposure upon differentiation. Importantly, histone deacetylase inhibition using vorinostat restores R-loop formation, slows down DNA replication forks and improves SF3B1-mutated erythroblast differentiation. In conclusion, loss of R-loops with associated DNA replication stress represents a hallmark of SF3B1-mutated MDS ineffective erythropoiesis, which could be used as a therapeutic target.

7 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
LDLeïla Dumas
Leïla Dumas
SSSauyeun Shin
Sauyeun Shin
QRQuentin Rigaud
Quentin Rigaud
MCMarie Cargnello
Marie Cargnello
Beatriz Hernández SuárezBeatriz Hernández Suárez
Beatriz Hernández Suárez
SMStefania Millevoi
Stefania Millevoi
Cancer cells rely on mitochondria for their bioenergetic supply and macromolecule synthesis. Central to mitochondrial function is the regulation of mitochondrial protein synthesis, which primarily depends on the cytoplasmic translation of nuclear-encoded mitochondrial mRNAs whose protein products are imported into mitochondria. Despite the growing evidence that mitochondrial protein synthesis contributes to the onset and progression of cancer, and can thus offer new opportunities for cancer therapy, knowledge of the underlying molecular mechanisms remains limited. Here, we show that RNA G-quadruplexes (RG4s) regulate mitochondrial function by modulating cytoplasmic mRNA translation of nuclear-encoded mitochondrial proteins. Our data support a model whereby the RG4 folding dynamics, under the control of oncogenic signaling and modulated by small molecule ligands or RG4-binding proteins, modifies mitochondria-localized cytoplasmic protein synthesis. Ultimately, this impairs mitochondrial functions, affecting energy metabolism and consequently cancer cell proliferation.

1 July 2021 in Differentiation
Verified
Journal Article
Closed access
MDMathieu Danoy
Mathieu Danoy
RJRachid Jellali
Rachid Jellali
YTYannick Tauran
Yannick Tauran
JBJohanna Bruce
Johanna Bruce
MLMarjorie Leduc
Marjorie Leduc
ELEric Leclerc
Eric Leclerc

18 July 2025 in Blood Red Cells & Iron
Verified
Journal Article
Open access
MLMarjorie Leduc
Marjorie Leduc
JPJulien Papoin
Julien Papoin
HYHongxia Yan
Hongxia Yan
MGMorgane Le Gall
Morgane Le Gall
WNWassim El Nemer
Wassim El Nemer
LBLionel Blanc
Lionel Blanc
Reticulocyte maturation, the final stage of erythropoiesis following enucleation, is a dynamic 48- to 72-hour process remodeling multi-lobular, motile, and fragile nascent reticulocytes into deformable, biconcave red blood cells. This maturation involves organelle clearance and extensive membrane remodeling. A significant knowledge gap in our understanding is a lack of knowledge of the proteins involved in the earliest stages of reticulocyte maturation, the nascent bone marrow reticulocyte. To address this, we isolated and characterized the proteomic profiles of distinct reticulocyte populations from healthy human bone marrow. Density gradient separation, FACS analyses, and electron microscopy revealed a continuum of different stages of reticulocyte maturation in the marrow. Deformation-induced micropipette aspiration analyses combined with imaging of membrane proteins labeled with specific fluorescent probes, performed to better understand mechanisms of decreased expression of surface proteins during reticulocyte maturation, revealed a correlation between the extent of linkage and the decreased expression of surface proteins during reticulocyte maturation. There was a marked decrease in the total protein content between nascent and mature reticulocytes (56 to 39pg/cell) with a modest decrease between mature reticulocytes and mature erythrocytes (39 to 37pg/cell). Comparison of proteomes from nascent reticulocytes (2532 unique proteins), mature reticulocytes, and mature erythrocytes revealed only 867 proteins were shared among the three populations with significant changes in many classes of proteins. These studies provide comprehensive insights into maturation of the human reticulocyte proteome, advancing our understanding of the molecular mechanisms governing this process, and offer potential implications for acquired and inherited red blood cell disorders.